通精冲剂与手术治疗精索静脉曲张不育症的临床研究

目的进一步观察通精冲剂治疗精索静脉曲张不育症的治疗效果。方法将75例Ⅱ(中度)～Ⅲ度(重度)精索静脉曲张伴精液质量异常的不育患者，分成中药治疗组(44例)与手术治疗组(31例)进行对照研究。中药组采用通精冲剂治疗，手术组采用精索静脉高位结扎术或(和)加腹壁下静脉转流术。所有患者均定期复诊或随访。用精液电脑自动分析仪(CASA)对两组治疗前后的精子计数、活率、各项运动参数以及配偶怀孕等情况进行观察。结果治疗前中药组与手术组各项指标大多差异无显著性，中药组精子密度、运动精子数、前向运动精子数等低于手术组；治疗后中药组CASA分析，精子质量明显改善，而手术组手术前后差异无显著性(P＞0.05)。结论用通精冲剂治疗精索静脉曲张引起不育症，可达到手术治疗的临床效果，而且精子运动参数改善明显。表明手术治疗仅单纯改善局部情况，而中药通精冲剂治疗还能进一步调节全身功能。     

Effect of Zhuyeshigao granule on tumor necrosis factor-α and interleukins serum protein levels in rats with radiation esophagitis

Objective

To investigate the effects of Zhuyeshigao granule (ZSG) on tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-2, IL-6, and IL-8 in rats with radiation esophagitis.

Methods

Fifty Wistar rats were randomly divided into five groups (10 rats in each group): control (without radiation), saline-treated, and low, medium, and high-dose ISG-treated groups. Rats were given normal saline (10 mL/kg) or 1.15, 2.3, or 4.6 g/kg ZSG by intragastric administration once a day for 7 days. A rat model of radiation esophagitis was established by local irradiation of Co60 (490.25 cGy/min, totaling 30 Gy). The administration of ZSG was continued for another 7 days and on the 7th day post-irradiation, inferior vena cava blood was collected. The serum was separated, and TNF-α, IL-1, IL-2, IL-6, and IL-8 protein levels were determined.

Results

Inflammatory response factors were found in the serum of each group. However, levels in ZSG-treated groups were significantly lower than in the saline-treated group (P<0.05).

Conclusion

ZSG may prevent the development of radiation esophagitis, perhaps by inhibiting the generation and release of the inflammatory response factors TNF-α, IL-1, IL-2, IL-6, and IL-8.     

胃溃疡活动期“毒热”创新病因的系统研究

目的:课题以研究胃溃疡活动期的中医"毒热"病因理论为突破口,以建立中医病因学研究方法为途径,以阐明中医药治疗胃癌前状态性疾病的疗效机制为特色,丰富和发展中医病因学理论和实践。方法:通过中医胃脘病"毒热"病因理论研究、中医"毒热"实验病因学研究、"毒热"病因要素的临床流行病学调查、"毒热"病因的中药干预验证性临床试验,进行系统研究。结果:通过病例对照设计,581例胃溃疡活动期83.3%为毒热证;266例浅表性胃炎13.3%为毒热证,从而确证胃溃疡活动期"毒热"为多发、常见病因,通过多因素Logistic回归分析,辨证求因要点包括幽门螺杆菌(Hp)感染、胆汁反流、炎症因子增高、胃肠激素分泌异常等。经300例随机双盲双模拟多中心对照临床试验,试验组证候积分愈显率86.62%,胃镜愈显率80.29%。改良胃溃疡活动期胃毒热证的实验动物模型及其评价方法,验证清热解毒、消痈生肌治法中药复方疗效确切,并阐明其生物学机制。结论:"毒热"为胃溃疡活动期的主要病因,"以痈论治"胃溃疡活动期的新治法为清热解毒、消痈生肌,疗效显著。     

稳心颗粒联合倍他乐克治疗冠心病合并室性早搏的临床观察

目的:观察稳心颗粒联合倍他乐克治疗冠心病合并室性早搏的临床疗效及安全性。方法:将108例冠心病合并室性早搏患者随机分为治疗组和对照组各54例,治疗组给予稳心颗粒联合倍他乐克治疗,对照组仅给予服倍他乐克治疗,比较两组患者的动态心电图结果、临床疗效及不良反应。结果:治疗组的动态心电图结果和临床疗效均优于对照组,且差异有统计学意义(P<0.05)。两组患者的不良反应发生率比较无明显差异(P>0.05)。结论:稳心颗粒联合倍他乐克治疗冠心病合并室性早搏疗效优于单用倍他乐克,且联合用药可减小倍他乐克的使用剂量,不良反应小,患者的耐受性好,值得临床借鉴。     

补中益气颗粒对产后盆底功能障碍患者盆底肌力及外周血TGF-β_1、IGF-1的影响

目的:观察补中益气颗粒对产后盆底功能障碍患者盆底肌力以及外周血TGF-β1、IGF-1的影响。方法:将110例产后盆底功能障碍患者随机分为两组,对照组48例采取Kegel法锻炼;观察组52例在对照组的基础上加用补中益气颗粒,观察两组治疗前后盆底肌力及TGF-β1、IGF-1的变化。结果:观察组的盆底肌力、TGF-β1、IGF-1变化均优于对照组,差异有统计学意义(P0.05)。结论:补中益气颗粒可提高产后盆底功能障碍患者的盆底肌力,其机理可能与影响TGF-β1、IGF-1合成与释放有关。     

高效液相色谱法测定雄芍颗粒中芍药苷的含量

目的:采用高效液相色谱法测定雄芍颗粒中芍药苷的含量。方法:采用HPLC法,色谱柱:Diamonsil C18(250 mm×4.6 mm,5μm);流动相:乙腈-0.1%磷酸溶液(14∶86);流速:1.0 mL/min;检测波长:230 nm。结果:芍药苷在0.107 8~2.156 0μg线性关系良好(r=0.999 7);平均回收率为99.26%,RSD为2.06%(n=5)。结论:该方法简便、准确、可靠、重现性好,可用于雄芍颗粒的质量控制。     

通阳宽胸颗粒治疗冠心病支架植入术后心绞痛60例临床观察

目的：观察通阳宽胸颗粒治疗冠心病支架植入术后心绞痛的疗效。方法：将122例冠心病冠脉支架植入术后心绞痛患者随机分为治疗组60例与对照组62例。对照组采用西医常规治疗,治疗组在对照组治疗的基础上加用通阳宽胸颗粒治疗。结果：心绞痛症状疗效,治疗组为88.33%,对照组为74.19%;心电图疗效,治疗组为86.67%,对照组为70.97%;中医证候疗效,治疗组为91.67%,对照组为69.35%。各项组间比较,差异均有统计学意义（P〈0.05）,治疗组均优于对照组。结论：通阳宽胸颗粒治疗冠心病心绞痛有较好疗效。     

Busuishengxue ranules mediate their effects upon non-severe aplastic anemia via mitogen-activated protein kinase/extracellular signal-regulated kinase pathway

OBJECTIVE：To observe the clinical efficacy of Busu- ishengxue granules on non-severe aplastic anemia（NSAA） and investigate its effect on the mitogen-ac- tivated protein kinase/extracellular signal-regulat- ed kinase（MAPK/ERK） pathway. METHODS： Sixty NSAA patients were divided equally into two groups. Subjects in the experimen- tal group were treated with Busuishengxue gran- ules, and the control group with Zaizaoshengxue tablets.The treatment course was 6 months and cu-rative efficacy was compared between the two groups as well as with 10 healthy individuals. Flow cytometry（FCM） was used to detect the intracellu- lar concentration of Ca2 ＋（[Ca2 ＋]i）. Western blotting was employed to detect the expression of enzymes in the MAPK/ERK pathway. RESULTS： The efficacy of Busuishengxue granules was significantly better than that of Zaizaoshengx- ue tablets（P0.05）. Before treatment, expression of JNK, phospho-ERK 1/2 and p-JNK was higher, and [Ca2 ＋]i higher, than that of the control group（P 0.05）. After treatment with Busuishengxue gran- ules, expression of all enzymes related to signal transduction pathways in the blood cells of NSSA patients were altered to different degrees. CONCLUSION： Busuishengxue granules had a bet- ter effect with regard to improving symptom scores, increasing the number of blood leukocytes, and increasing hemoglobin levels than Zaizaosh- engxue tablets, and they differed slightly in terms of increasing the number of platelets.     

两种内服医院中药制剂微生物限度检查方法验证

目的：建立儿康合剂和清咽宁颗粒的微生物限度检查方法。方法：通过2种制剂对5个试验菌种的回收率来确定检查方法,同时验证控制菌大肠埃希菌的检查方法。结果：儿康宁合剂对5个规定菌株的正常生长无影响;清咽宁对大肠埃希菌、枯草芽孢杆、白色念珠菌和黑曲霉的没有生物毒性,但抑制金黄色葡萄球菌的生长。结论：可采用常规法检查儿康宁合剂的霉菌、酵母菌数和细菌总数以及控制菌;采用培养基稀释法检查清咽宁颗粒细菌总数,常规法检查霉菌、酵母菌数和控制菌。     

疏血通注射液联合尿毒清颗粒治疗慢性肾衰竭的临床研究

目的探讨尿毒清颗粒剂与疏血通注射液结合治疗慢性肾衰竭（CRF）的临床疗效。方法将符合入选标准的108例患者随机分成三组,尿毒清组单独口服尿毒清颗粒进行治疗,疏血通组单独注射疏血通注射液进行治疗,混合组（尿毒清颗粒剂与疏血通注射液结合组）在注射疏血通注射液的基础上配合服用尿毒清颗粒。结果对比各组治疗前和治疗后数据,得出疏血通组和尿毒清组都有统计学意义,混合组有显著疗效。结论混合组治疗慢性肾衰竭比尿毒清组和疏血通组取得更显著疗效,值得在临床推广使用。